On day 20, the tumor inhibition rates of Hb group, Cur group, Cur@Hb group, IR group, Hb + IR group, Cur + IR group and Cur@Hb + IR group were 21.61%, 33.62%, 38.02%, 60.79%, 64.41%, 63.55% and 71.02%, respectively (Fig. 6B). Here, GSTM1 is linked to neoplasm.